Efficacy of switching to dolutegravir plus rilpivirine, the small-tablet regimen, in patients with dysphagia: two case reports

被引：6
|
作者：
Takefumi Suzuki
Nobuko Hara
Morichika Osa
Kazuhisa Misawa
Kazuo Imai
Yuji Fujikura
Takuya Maeda
Wataru Sonehara
Akihiko Kawana
机构：
[1] National Defense Medical College Hospital,Department of Pharmacy
[2] National Defense Medical College,Division of Infectious Diseases and Pulmonary Medicine, Department of Internal Medicine
[3] Mishuku Hospital,Department of Pharmacy
[4] Saitama Medical University,Department of Microbiology
[5] Saitama Medical University,Center for Clinical Infectious Diseases and Research
来源：
Journal of Pharmaceutical Health Care and Sciences | / 3卷 / 1期
关键词：
Dolutegravir; Rilpivirine; Dysphagia; NRTI-sparing;
D O I：
10.1186/s40780-017-0093-8
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Dolutegravir plus rilpivirine as dual regimen in virologically suppressed HIV-1 infected patients in a clinical setting
    Casado, Jose L.
    Monsalvo, Marta
    Fontecha, Maria
    Vizcarra, Pilar
    Rodriguez, Miguel A.
    Vivancos, Maria Jesus
    Moreno, Santiago
    HIV RESEARCH & CLINICAL PRACTICE, 2019, 20 (02) : 64 - 72
  • [2] Efficacy and tolerability of dolutegravir/lamivudine versus dolutegravir/rilpivirine in switching from a three-drug regimen based on nonnucleoside reverse transcriptase inhibitors: A retrospective cohort study
    Lagi, Filippo
    Giacomelli, Andrea
    Borghi, Vanni
    Ciccullo, Arturo
    Taramasso, Lucia
    Madeddu, Giordano
    D'Ettorre, Gabriella
    Giacometti, Andrea
    Ducci, Filippo
    De Vito, Andrea
    Pincino, Rachele
    Di Giambenedetto, Simona
    Mussini, Cristina
    Antinori, Spinello
    Sterrantino, Gaetana
    JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (10)
  • [3] Bioequivalence of a Fixed-Dose Combination Tablet of the Complete Two-Drug Regimen of Dolutegravir and Rilpivirine for Treatment of HIV-1 Infection
    Mehta, Rashmi
    Wolstenholme, Allen
    Di Lullo, Kristin
    Fu, Caifeng
    Joshi, Shashidhar
    Crauwels, Herta
    Givens, Naomi
    Vanveggel, Simon
    Wynne, Brian
    Adkison, Kimberly
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (09)
  • [4] Rildo: Real-World Multicenter Study on the Effectiveness and Safety of Single-Tablet Regimen of Dolutegravir plus Rilpivirine in Treatment-Experienced People Living with HIV
    Hidalgo-Tenorio, Carmen
    Vinuesa, David
    Garcia-Vallecillos, Coral
    Munoz-Medina, Leopoldo
    Sequera, Sergio
    Javier, Rosario
    Angel Lopez-Ruz, Miguel
    Sadyrbaeva-Dolgova, Svetlana
    Pasquau, Juan
    VIRUSES-BASEL, 2022, 14 (12):
  • [5] Switching to emtricitabine, tenofovir and rilpivirine as single tablet regimen in virologically suppressed HIV-1-infected patients: a cohort study
    Gantner, P.
    Reinhart, S.
    Partisani, M.
    Baldeyrou, M.
    Batard, M-L
    Bernard-Henry, C.
    Cheneau, C.
    de Mautort, E.
    Priester, M.
    Fafi-Kremer, S.
    Muret, P.
    Rey, D.
    HIV MEDICINE, 2015, 16 (02) : 132 - 136
  • [6] Patient-reported outcomes after switching to a two-drug regimen of dolutegravir plus rilpivirine: Week 100 results from the SWORD-1 and SWORD-2 studies
    Oglesby, A.
    Angelis, K.
    Punekar, Y.
    Lopes, S.
    Antela, A.
    Aboud, M.
    Blair, E.
    Kahl, L.
    Gartland, M.
    Wynne, B.
    Murray, M.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2018, 21
  • [7] Switching from a two-tablet regimen of tenofovir/emtricitabine and efavirenz to a one-tablet regimen may affect patients' perceptions and drug management
    Rotzinger, A.
    Locatelli, I.
    Bugnon, O.
    Mello, A. Fayet
    Parienti, J-J
    Cavassini, M.
    Schneider, M. P.
    HIV MEDICINE, 2016, 17 (05) : 390 - 396
  • [8] Efficacy and Safety of Two-Drug Regimens with Dolutegravir plus Rilpivirine or Lamivudine in HIV-1 Virologically Suppressed People Living with HIV
    Duenas-Gutierrez, Carlos
    Buzon, Luis
    Pedrero-Tome, Roberto
    Iribarren, Jose A.
    De los Santos, Ignacio
    De la Fuente, Sara
    Pousada, Guillermo
    Moran, Miguel Angel
    Moreno, Estela
    Ferreira, Eva
    Gomez, Julia
    Troya, Jesus
    VIRUSES-BASEL, 2023, 15 (04):
  • [9] Two case reports of severe myocarditis associated with the initiation of dolutegravir treatment in HIV patients
    Mahlab-Guri, Keren
    Asher, Ilan
    Rosenberg-Bezalel, Shira
    Elbirt, Daniel
    Burke, Michael
    Sthoeger, Zev M.
    MEDICINE, 2016, 95 (47)
  • [10] Efficacy and safety of switching to dolutegravir plus rilpivirine in virologically suppressed older PLWHIV: pooled week 148 results from SWORD-1 and SWORD-2
    Prakash, M.
    Grove, R.
    Wynne, B.
    van Wyk, J.
    Jones, B.
    Clark, A.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2022, 25 : 93 - 94
12345